Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Using free patches to improve reach of the Oregon Quit Line.

Deprey M, McAfee T, Bush T, McClure JB, Zbikowski S, Mahoney L.

J Public Health Manag Pract. 2009 Sep-Oct;15(5):401-8. doi: 10.1097/PHH.0b013e3181952345.

PMID:
19704308
2.

The impact of a free nicotine patch starter kit on quit rates in a state quit line.

Bush TM, McAfee T, Deprey M, Mahoney L, Fellows JL, McClure J, Cushing C.

Nicotine Tob Res. 2008 Sep;10(9):1511-6. doi: 10.1080/14622200802323167.

PMID:
19023843
3.

Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks.

McAfee TA, Bush T, Deprey TM, Mahoney LD, Zbikowski SM, Fellows JL, McClure JB.

Am J Prev Med. 2008 Aug;35(2):103-10. doi: 10.1016/j.amepre.2008.04.017.

PMID:
18617079
4.

Giving away free nicotine medications and a cigarette substitute (Better Quit) to promote calls to a quitline.

Bauer JE, Carlin-Menter SM, Celestino PB, Hyland A, Cummings KM.

J Public Health Manag Pract. 2006 Jan-Feb;12(1):60-7.

PMID:
16340517
5.

Cost effectiveness of the Oregon quitline "free patch initiative".

Fellows JL, Bush T, McAfee T, Dickerson J.

Tob Control. 2007 Dec;16 Suppl 1:i47-52.

6.

Nicotine patch therapy prior to quitting smoking: a meta-analysis.

Shiffman S, Ferguson SG.

Addiction. 2008 Apr;103(4):557-63. doi: 10.1111/j.1360-0443.2008.02138.x. Review.

PMID:
18339101
7.

Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.

Rose JE, Herskovic JE, Behm FM, Westman EC.

Nicotine Tob Res. 2009 Sep;11(9):1067-75. doi: 10.1093/ntr/ntp103. Epub 2009 Jun 30.

PMID:
19567826
8.

Utilization of a tobacco quit line prior to and after a tobacco tax increase.

Harwell TS, Lee L, Haugland C, Wilson SM, Campbell SL, Holzman GS, Gohdes D, Helgerson SD.

J Public Health Manag Pract. 2007 Nov-Dec;13(6):637-41.

PMID:
17984719
9.

Tobacco quitline use: enhancing benefit and increasing abstinence.

Campbell SL, Lee L, Haugland C, Helgerson SD, Harwell TS.

Am J Prev Med. 2008 Oct;35(4):386-8. doi: 10.1016/j.amepre.2008.06.032. Epub 2008 Aug 3.

PMID:
18675528
10.

Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.

Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.

Clin Drug Investig. 2009;29(10):655-65. doi: 10.2165/11317730-000000000-00000.

PMID:
19715382
11.

The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.

Lewis SA, Haw SJ, McNeill A.

Nicotine Tob Res. 2008 Dec;10(12):1789-92. doi: 10.1080/14622200802443510.

PMID:
19023830
12.

Clinical faxed referrals to a tobacco quitline: reach, enrollment, and participant characteristics.

Willett JG, Hood NE, Burns EK, Swetlick JL, Wilson SM, Lang DA, Levinson AH.

Am J Prev Med. 2009 Apr;36(4):337-40. doi: 10.1016/j.amepre.2008.12.004. Epub 2009 Feb 6.

PMID:
19201150
13.

Maine's Tobacco Medication Program: compliance, patterns of use, and satisfaction among smokers.

Tworek C, Haskins A, Woods S.

Nicotine Tob Res. 2009 Jul;11(7):904-7. doi: 10.1093/ntr/ntp085. Epub 2009 May 25.

PMID:
19468080
14.

Impact of national ABC promotion on 1-800-QUIT-NOW.

Hurd AL, Augustson EM, Backinger CL, Deaton C, Bright MA.

Am J Health Promot. 2007 Jul-Aug;21(6):481-3.

PMID:
17674633
15.

Using direct mail to prompt smokers to call a quitline.

O'Connor RJ, Carlin-Menter SM, Celestino PB, Bax P, Brown A, Cummings KM, Bauer JE.

Health Promot Pract. 2008 Jul;9(3):262-70. doi: 10.1177/1524839906298497. Epub 2008 Feb 28.

PMID:
18308952
16.

The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.

Escobar-Chávez JJ, Merino V, López-Cervantes M, Rodríguez-Cruz IM, Quintanar-Guerrero D, Ganem-Quintanar A.

Curr Drug Discov Technol. 2009 Sep;6(3):171-85. Epub 2009 Sep 1. Review.

PMID:
19496753
17.

Adverse effects with use of nicotine replacement therapy among quitline clients.

Ossip DJ, Abrams SM, Mahoney MC, Sall D, Cummings KM.

Nicotine Tob Res. 2009 Apr;11(4):408-17. doi: 10.1093/ntr/ntp005. Epub 2009 Mar 26.

PMID:
19325134
18.

Summaries for patients. Comparison of 3 strategies to quit smoking.

[No authors listed]

Ann Intern Med. 2009 Apr 7;150(7):I-36. No abstract available.

PMID:
19349626
19.

Cost-effectiveness of varenicline for smoking cessation.

Keiding H.

Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):215-21. doi: 10.1586/erp.09.19.

PMID:
19527093
20.

[Commentary] improving NRT labeling and correcting public misperceptions.

Foulds J.

Addiction. 2008 Aug;103(8):1379-80. doi: 10.1111/j.1360-0443.2008.02313.x. No abstract available.

PMID:
18855828

Supplemental Content

Support Center